In a landmark medical achievement, Dr. Sher Bahadur Anjum, a British-Pakistani hematologist originally from Gilgit-Baltistan, has successfully treated two young thalassaemia patients using revolutionary gene therapy in the United Kingdom.
The children, aged 11 and 13, were previously dependent on monthly blood transfusions to survive. Thanks to this cutting-edge treatment, both are now living healthy, transfusion-free lives.
Woman Who Gave Birth to Triplets Now Delivers five healthy babies at once
Dr. Anjum carried out the therapy in collaboration with Newham Hospital and Great Ormond Street Hospital, two of the UK’s leading medical institutions. The process involved months of detailed preparation, genetic evaluation, and extensive counseling for the families before administering the treatment.
The successful outcome has not only transformed the future of these children but also offers a new ray of hope to millions of thalassaemia patients worldwide who suffer from the life-long burden of frequent transfusions.
“This is more than a medical success – it’s a story of resilience, science, and compassion,” Dr. Anjum said, emphasizing the global potential of gene therapy in curing genetic blood disorders.
Medical experts have hailed the achievement as a breakthrough for the South Asian community, where thalassaemia is particularly common.
